BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2004
View Archived Issues
New subunit-selective GABA-A receptor ligands developed at Merck
Read More
New antiangiogenic agents prepared and tested at ExonHit
Read More
Two series of chemokine CCR8 antagonists claimed by GSK researchers
Read More
Biofrontera presents a novel antibiotic with anti-H. pylori activity
Read More
Novel glucocorticoid receptor modulators designed at Boehringer Ingelheim
Read More
Schering AG presents three series of estratriene-based antimitotic agents
Read More
GSK patent covers new anti-HCV NS5B inhibitors
Read More
Provid scientists present new MHC binding modulators for multiple sclerosis and other disorders
Read More
Rivastigmine reported to improve cognition in schizophrenic patients
Read More
Clinical evidence of the effects of the SERM HMR-3339 in postmenopausal women
Read More
PBT-1 to enter phase II/III study in 2005
Read More
Chiron submits Pulminiq NDA
Read More
Pramipexole for Parkinson's disease returns to Boehringer Ingelheim
Read More
AERES Biomedical completes humanization of Peregrine's 3G4 antibody
Read More
Traditional approval for Fuzeon
Read More
European approval for Kogenate Bayer with Bio-Set
Read More
Hedley Technologies to acquire Medicor
Read More
Arpida acquires Combio
Read More
FDA approval for Campath single-dose vial
Read More
Second phase I study for SNS-595
Read More
Cambrex to market and distribute Orcel
Read More
Tissue Repair Cell study expanded
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: Genetronics Biomedical
Read More
Pfizer sponsors new study of Celebrex
Read More
Phase III findings on Ampligen for chronic fatigue syndrome
Read More
Argenes and Santen sign Japanese agreement for anti-APO-1 antibody
Read More
Vardenafil subject of various presentations at ISSIR
Read More
ACE inhibitors show promise in Alzheimer's disease
Read More
CP-113818 reduces amyloid plaques in Alzheimer's model
Read More
Prous Science webcasts key lecture sessions from the 27th SIU Congress
Read More